Killing cancer cells by rupturing their lysosomes
Source abstract
Abstract
Nanoparticles covered with a mix of positively and negatively charged ligands aggregate into supraparticles in the lysosomes of cancer cells, disrupting the integrity of the lysosomal membrane and killing the cells without involving any anticancer drugs.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (8)
Show source-provided references
1. Sun, T. et al. Angew. Chem. Int. Ed. 53, 12320–12364 (2014).10.1002/anie.201403036 ↗
2. Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).10.1038/nrc.2016.108 ↗
3. Lammers, T. et al. Nat. Rev. Mater. 1, 16069 (2016).10.1038/natrevmats.2016.69 ↗
4. Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016).10.1038/natrevmats.2016.14 ↗
5. Borkowska, M. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-020-0643-3 (2020).10.1038/s41565-020-0643-3 ↗
6. Gilroy, K. D. & Xia, Y. Chem. Asian J. 11, 2341–2351 (2016).10.1002/asia.201600979 ↗
7. Damaghi, M., Wojtkowiak, J. W. & Gillies, R. J. Front. Physiol. 4, 370 (2013).10.3389/fphys.2013.00370 ↗
8. Domagala, A. et al. Int. J. Mol. Sci. 19, 2256 (2018).10.3390/ijms19082256 ↗